Assessing Quality of Life in Older Adults With Cognitive Impairment
By R. Logsdon, L. Gibbons, S. McCurry, L. Teri. Psychosomatic Medicine, 2002
1,403 citations recorded by the source corpus.
Subfields: General Health Professions, Psychiatry and Mental health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/1042f94af3a518cc9b1eeb6193f20227a5573768
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Lozano
- A. Laxton
- Clement Hamani
- David F. Tang‐Wai
- Gwenn S. Smith
- R. Keren
- G. Naglie
- R. Wennberg
Citations in the corpus
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease (2010, neutral): “the ADCS’s activities of daily living (ADCS-ADL) scale,(19) the Neuropsychiatric Inventory (NPI),(20) and the Quality of Life Alzheimer’s Disease scale.(21) All outcome measures were obtained at baseline, 6 months, 12 months, and 18 months with the exception of the MMSE, which was obtained at baseli”
- A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease (2010, methodology): “Clinicians’ Interview-Based Impression of Change Plus Caregiver Input,(43) and the Quality of Life Alzheimer Disease Scale.(44) MMSE data were available 1 year prior to the patients”